Search Within

Parastoo Bahrami Dahi

  1. "Master of Science in Clinical and Translational Cancer Research "
Formats
  1. Meeting Abstract (177)
  2. Journal Article (95)
  3. Research Letter (10)
  4. Review (8)
  5. Book Section (1)
  6. Correspondence (1)
  7. Editorial (1)
  8. Guidelines (1)
Groups
  1. Bone Marrow Transplant (294)
  2. CTCR Scholars (294)
  3. Center for Hematologic Malignancies (294)
  4. Department of Medicine (294)
  5. Hematologic Malignancies, Division of (294)
  6. MSK Grad Students (294)

More Groups

People
  1. Sergio Giralt (206)
  2. Miguel-Angel Perales (189)
  3. Gunjan Shah (155)
  4. Sean Devlin (155)
  5. Craig Sauter (135)
  6. Michael Scordo (133)

More People

Years
  1. 2025 (9)
  2. 2024 (19)
  3. 2023 (39)
  4. 2022 (27)
  5. 2021 (24)
  6. 2020 (47)

More Years

Publications
  1. Blood (86)
  2. Biology of Blood and Marrow Transplantation (69)
  3. Bone Marrow Transplantation (26)
  4. Transplantation and Cellular Therapy (25)
  5. Blood Advances (19)
  6. Leukemia and Lymphoma (8)

More Publications

Publishers
  1. American Society of Hematology (105)
  2. Elsevier Inc. (104)
  3. Nature Publishing Group (32)
  4. Taylor & Francis Group (10)
  5. Wiley Blackwell (8)
  6. American Society of Clinical Oncology (7)

More Publishers

Results (294)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Site-specific responses and extranodal involvement implications in large B-cell lymphomas treated with CD19-CART therapy
    Meeting Abstract

    Luna de Abia, A.; Devlin, S. M.; Flynn, J.; Corona De Lapuerta, M.; Luttwak, E.; Landego, I.; Dahi, P. B.; Lin, R. J.; Parascondola, A.; Palomba, M. L.; more...
    Bone Marrow Transplantation (2024)

    Fulltext@MSK | Save
  • Central nervous system bridging radiotherapy (CNS-BRT) achieves rapid cytoreduction prior to car T-cell therapy for aggressive B-cell lymphomas
    Meeting Abstract

    Cederquist, G.; Schefflein, J.; Devlin, S.; Shah, G.; Shouval, R.; Hubbeling, H.; Tringale, K.; Fregonese, B.; Hajj, C.; Boardman, A.; more...
    Neuro-Oncology (2024)

    Fulltext@MSK | Save
  • A proof-of-principle study of split-course bridging radiotherapy (SC-BRT) prior to commercial CAR T-cell therapies for relapsed or refractory B-cell lymphomas: Results from phase 1a pilot cohort
    Meeting Abstract

    Imber, B. S.; Palomba, M. L.; Brosoff, A.; Roszak, E.; McAvoy, D.; Hosszu, K.; Boardman, A.; Dahi, P. B.; Lin, R. J.; Shah, G. L.; more...
    International Journal of Radiation Oncology, Biology, Physics (2024)

    Fulltext@MSK | Save
  • Improvement in radiomic features following bridging therapy is prognostic for CD19 chimeric antigen receptor (CAR) T-cell therapy outcome
    Meeting Abstract

    Hubbeling, H. G.; Leithner, D.; Silverman, E. A.; Flynn, J.; Devlin, S.; Shah, G. L.; Fregonese, B.; Bedmutha, A.; Boardman, A.; Dahi, P. B.; more...
    International Journal of Radiation Oncology, Biology, Physics (2024)

    Fulltext@MSK | Save
  • Clinical features, pathophysiology, and management of acute myelopathy following CAR T-cell therapy
    Review

    Deschè‚nes-Simard, X.; Santomasso, B. D.; Dahi, P. B.
    Blood (2024)

    Fulltext@MSK | Save
  • Anti-CD19 chimeric antigen receptor T-cell therapy has less efficacy in Richter transformation than in de novo large B-cell lymphoma and transformed low-grade B-cell lymphoma
    Journal Article

    Benjamini, O.; Fried, S.; Shouval, R.; Flynn, J. R.; Beyar-Katz, O.; Leslie, L. A.; Zuckerman, T.; Yerushalmi, R.; Shem-Tov, N.; Palomba, M. L.; more...
    Haematologica (2024)

    Fulltext@MSK | Save
  • Metabolic tumor volume response after bridging therapy determines chimeric antigen receptor T-cell outcomes in large B-cell lymphoma
    Journal Article

    Hubbeling, H.; Leithner, D.; Silverman, E. A.; Flynn, J.; Devlin, S.; Shah, G.; Fregonese, B.; Wills, B.; Bedmutha, A.; Alarcon Tomas, A.; more...
    Clinical Cancer Research (2024)

    Fulltext@MSK | Save
  • Atrial arrhythmias following CAR-chimeric antigen receptor T-cell therapy: Incidence, risk factors and biomarker profile
    Journal Article

    Shouval, R.; Goldman, A.; Flynn, J. R.; El-Moghraby, A.; Rehman, M.; Devlin, S. M.; Corona, M.; Landego, I.; Lin, R. J.; Scordo, M.; more...
    British Journal of Haematology (2024)

    Fulltext@MSK | Save
  • CNS bridging radiotherapy achieves rapid cytoreduction before CAR T-cell therapy for aggressive B-cell lymphomas
    Journal Article

    Cederquist, G. Y.; Schefflein, J.; Devlin, S. M.; Shah, G. L.; Shouval, R.; Hubbeling, H.; Tringale, K.; Tomas, A. A.; Fregonese, B.; Hajj, C.; more...
    Blood Advances (2024)

    Fulltext@MSK | Save
  • Subsequent malignancies after CD19-targeted chimeric antigen receptor T cells in patients with lymphoma
    Journal Article

    Lorenc, R.; Shouval, R.; Flynn, J. R.; Devlin, S. M.; Saldia, A.; Luna De Abia, A.; De Lapuerta, M. C.; Tomas, A. A.; Cassanello, G.; Leslie, L. A.; more...
    Transplantation and Cellular Therapy (2024)

    Fulltext@MSK | Save